HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, HIF-1α expression is maintained in any condition of chronic phase CML patients due to physiologically hypoxic state and the effect of IM treatment towards bone marrow to preserve both leukemic and healthy stem cells.